425: Strive CFO Discusses Semler Scientific Merger on X.com

Strive's CFO, Ben Pham, communicated on X.com regarding the proposed business combination with Semler Scientific, emphasizing cautionary forward-looking statements.

Summary

• Strive, Inc. CFO Ben Pham posted on X.com on September 22, 2025, about the proposed business combination with Semler Scientific, Inc.
• The communication serves as a cautionary statement regarding forward-looking statements related to the merger.
• The proposed transaction is expected to yield strategic and financial benefits, including cost savings and successful integration, though these are subject to inherent risks and uncertainties.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus, with the SEC for the transaction.

Sentiment

Score: 5

Explanation: The filing is a standard legal disclosure for a proposed merger, containing both the stated intent of strategic benefits and a comprehensive list of associated risks. It's neutral in tone, balancing potential upside with necessary cautionary statements.

Positives

• The proposed business combination is anticipated to bring strategic and financial benefits to the combined company.
• Expected benefits include anticipated cost savings and strategic gains.

Negatives

• The transaction may not close when expected or at all due to unfulfilled conditions.
• Anticipated benefits, including cost savings and strategic gains, may not be realized.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The transaction may be more expensive or take longer to complete than anticipated.
• Management's attention may be diverted from ongoing business operations.
• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Potential for adverse reactions from customers and changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing could occur.

Risks

• The merger agreement between Strive and Semler Scientific could be terminated.
• Conditions to closing the proposed transaction may not be received or satisfied on a timely basis or at all, preventing the transaction from closing.
• Legal proceedings may be instituted against Strive or Semler Scientific or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized due to various factors, including changes in Bitcoin treasury strategies and risks associated with digital assets, general economic conditions, and regulatory changes.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including cost savings and successful integration. However, these are forward-looking statements subject to significant risks and uncertainties, including those related to market conditions, regulatory changes, and the integration process.

Management Comments

• Ben Pham, Chief Financial Officer of Strive, Inc., posted on X.com regarding the proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights the increasing relevance of "Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets" as a factor influencing the realization of anticipated benefits from the merger. This suggests that at least one of the companies, likely Semler Scientific given its recent public statements, is involved in or considering significant digital asset holdings, which is a notable trend in some corporate treasury management.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company could impact the transaction.

Related Party Transactions

• Information about Semler Scientific's transactions with related persons is set forth in its definitive proxy statement for its 2025 Annual Meeting of Stockholders.

Stakeholder Impact

• Shareholders: Potential for dilution for Strive shareholders due to new share issuance; need to approve the transaction (Semler Scientific shareholders); changes in share price before closing.
• Customers: Potential for adverse reactions from customers of both Strive and Semler Scientific.
• Employees: Potential for changes to employee relationships.
• Management: Diversion of management's attention from ongoing business operations.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC.
• The Registration Statement will include an Information Statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.

Key Dates

Recommendation

This filing is a procedural communication about a proposed merger, primarily serving as a cautionary statement regarding forward-looking information. While a merger announcement is inherently significant, this specific document does not provide new financial data or definitive terms that would warrant a strong buy or sell recommendation. It outlines potential benefits but also a comprehensive list of risks, suggesting a 'hold' until more definitive terms, financial impacts, and integration plans are disclosed in the upcoming S-4 filing. Investors should await further details before making a more decisive investment decision.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Digital Assets, Corporate Governance, Investment